Back to Search Start Over

CD4+CD25

CD4+CD25

Authors :
Avneesh K, Singh
Joshua L, Chan
Caleb N, Seavey
Philip C, Corcoran
Robert F, Hoyt
Billeta G T, Lewis
Marvin L, Thomas
David L, Ayares
Keith A, Horvath
Muhammad M, Mohiuddin
Source :
Xenotransplantation. 25(2)
Publication Year :
2017

Abstract

CD4+CD25Heterotopic cardiac xenotransplantation was performed on baboons using hearts obtained from GTKO.hCD46 (n = 8) and GTKO.hCD46.TBM (n = 5) genetically modified pigs. Modified immunosuppression regimen included antithymocyte globulin (ATG), anti-CD20, mycophenolate mofetil (MMF), cobra venom factor (CVF), and costimulation blockade (anti-CD154/anti-CD40 monoclonal antibody). FACS analysis was performed on PBLs labeled with anti-human CD4, CD25, and FoxP3 monoclonal antibodies (mAb) to analyze the percentage of Treg cells in six baboons that survived longer than 2 months (range: 42-945 days) after receiving a pig cardiac xenograft.Total WBC count was low due to immunosuppression in baboons who received cardiac xenograft from GTKO.hCD46 and GTKO.hCD46.hTBM donor pigs. However, absolute numbers of CD4+CD25Our results suggest that regulatory T (Treg) cells may contribute to preventing or delaying xenograft rejection by controlling the activation and expansion of donor-reactive T cells, thereby masking the antidonor immune response, leading to long-term survival of cardiac xenografts.

Details

ISSN :
13993089
Volume :
25
Issue :
2
Database :
OpenAIRE
Journal :
Xenotransplantation
Accession number :
edsair.pmid..........96d94933d494c349e6158297ada036e9